News / Press Releases - March 15, 2024
Negotiators from the European Council and the European Parliament reached a provisional agreement on the EHDS in the early morning of Friday, 15 March 2024. This means that there is just enough time for formal adoption before the new political mandate following the European elections… read more
Member Spotlight / News - February 5, 2024
Every month, EUCOPE spotlights a member company and the great work they’re doing to advance the life sciences industry and drive innovation to serve patients better. In February, we spoke with Enrico Piccinini, Head of Europe & International Rare Diseases, Chiesi Global Rare Diseases Enrico… read more
EUCOPE Resources / Events & Meetings - December 18, 2023
On 14 December, EUCOPE – the European Confederation of Pharmaceutical Entrepreneurs, hosted the fourth episode of its #LifeScienceLectures webinar series. The focus of the webinar, titled “Leveraging early advice opportunities in EU HTA” was to discuss how best to navigate early advice opportunities with the new… read more
Member Spotlight / News - September 20, 2023
Every month, EUCOPE spotlights a member company and the great work they’re doing to advance the life sciences industry and drive innovation to serve patients better. In September, we spoke with Francois Lontrade, Directeur General, Laboratoire Cevidra. Before joining Cevidra, Francois Lontrade gained 18 years’… read more
Member Spotlight - August 22, 2023
Every month, EUCOPE spotlights a member company and the great work they’re doing to advance the life sciences industry and drive innovation to serve patients better. In August, we spoke with Shekhar Natarajan, Vice President – EU Regulatory Affairs, Dyne Therapeutics. Shekhar Natarajan is Vice President-… read more
EUCOPE Resources / News - July 12, 2023
EUCOPE’S Sounds of Science Podcast – Episode 16 Rare Reflections: Impact of the OMP revision on rare disease companies in Europe On 26 April 2023, the European Commission published its long awaited proposal revising the foundational pharmaceutical legislation, including the Orphan Medicinal Products (OMP) Regulation…. read more
EUCOPE Resources / News - June 9, 2023
On 30 May, EUCOPE – the European Confederation of Pharmaceutical Entrepreneurs hosted the inaugural episode of its Life Science Lectures webinar series, “Attaching conditionalities to incentives: the right path to improve access?” The episode delved into the incentive system outlined in the EU Pharmaceutical Package,… read more
News / Press Releases - April 26, 2023
On the Commission’s proposal for the EU Pharmaceutical Package On 26 April, the European Commission published the EU Pharmaceutical Package, revising how the pharmaceutical system is regulated in the EU, which includes a proposal for a “master” Regulation, merging Commission Regulation No 726/2004, Orphan Medicinal… read more
Member Spotlight / News - March 31, 2023
Every month, EUCOPE spotlights a member company and the great work they’re doing to advance the life sciences industry and drive innovation to serve patients better. In March, we spoke with Adam Plich, Founder and CEO of Avanzanite Bioscience B.V. Adam Andrzej Plich is the… read more
EUCOPE Resources / Partnerships - March 14, 2023
Sounds of Science Podcast – Episode 14 Trans-Atlantic Innovation : Building bridges between the EU and US life sciences industry With the passing of the Inflation Reduction Act, significant changes are coming for drug pricing and payment in the United States. At the same time,… read more
